ESC Premium Access

Discussant review:Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Congress Session

About the speaker

Professor Jens Cosedis Nielsen

Aarhus University Hospital, Aarhus (Denmark)
17 presentations
8 followers

17 more presentations in this session

SPYRAL HTN OFF-MED Study

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Discussant review: SPYRAL HTN OFF-MED Study

Speaker: Professor B. Williams (London, GB)

Thumbnail

Panel discussion.

Thumbnail

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial

Speaker: Professor M. Ezekowitz (Philadelphia, US)

Thumbnail

Panel discussion.

Thumbnail

Access the full session

Hot Line: Late-Breaking Clinical Trials 2

Speakers: Professor J. Nielsen, Professor M. Boehm, Professor B. Williams, Professor M. Ezekowitz
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk